Verona Pharma plc (VRNA)
NASDAQ: VRNA · IEX Real-Time Price · USD
15.56
+0.09 (0.58%)
At close: Apr 29, 2024, 4:00 PM
16.01
+0.45 (2.89%)
After-hours: Apr 29, 2024, 7:12 PM EDT
Verona Pharma Employees
Verona Pharma had 79 employees on December 31, 2023. The number of employees increased by 43 or 119.44% compared to the previous year.
Employees
79
Change (1Y)
43
Growth (1Y)
119.44%
Revenue / Employee
n/a
Profits / Employee
-$688,215
Market Cap
1.21B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 79 | 43 | 119.44% |
Dec 31, 2022 | 36 | 10 | 38.46% |
Dec 31, 2021 | 26 | -1 | -3.70% |
Dec 31, 2020 | 27 | 2 | 8.00% |
Dec 31, 2019 | 25 | 10 | 66.67% |
Dec 31, 2018 | 15 | 3 | 25.00% |
Dec 31, 2017 | 12 | -3 | -20.00% |
Dec 30, 2017 | 15 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Phreesia | 1,438 |
Pacira BioSciences | 712 |
Deciphera Pharmaceuticals | 355 |
Ironwood Pharmaceuticals | 267 |
Collegium Pharmaceutical | 197 |
Scholar Rock Holding | 150 |
4D Molecular Therapeutics | 147 |
Belite Bio | 20 |
VRNA News
- 5 days ago - Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 2 months ago - Andrew Fisher Joins Verona Pharma as General Counsel - GlobeNewsWire
- 2 months ago - Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update - GlobeNewsWire
- 3 months ago - Michael Austwick Joins Verona Pharma as Non-Executive Director - GlobeNewsWire
- 4 months ago - Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital - GlobeNewsWire
- 5 months ago - Verona Pharma's President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award - GlobeNewsWire